#
Press Releases

Stay Informed with Our Latest Healthcare Updates and Announcements

Press Releases

Stay Informed with Our Latest Healthcare Updates and Announcements

Asset Publisher

Les pharmacies affiliées à Proxim et Uniprix lancent leur campagne annuelle de vaccination contre la grippe

Montréal (Québec), le 5 octobre 2022 — Les pharmacies affiliées à Proxim et Uniprix lancent leur campagne annuelle de vaccination contre la grippe.

« Au cours des dernières années, nos pharmaciens communautaires ont su démontrer qu’ils sont partie intégrante du système de santé québécois », a déclaré Erick Gagné, président-directeur général, Proxim et Uniprix. « Après avoir participé à l’effort de vaccination contre la COVID-19, les pharmaciens sont prêts, encore cette année, à vacciner les Québécois qui souhaitent se protéger et protéger leurs proches contre la grippe. »

L'activité grippale dans l'hémisphère Sud ayant été plus précoce par rapport aux années précédentes, la campagne de vaccination contre l'influenza a été devancée cette année et débutera le 5 octobre. Chaque année, des milliers de Québécois souffrent de la grippe, ce qui engorge davantage les hôpitaux et le système de santé. Bien que la plupart des gens se rétablissent après avoir contracté la grippe, celle-ci peut menacer la vie des personnes à risque, notamment celle des enfants, des aînés et des personnes atteintes de maladies chroniques.

Consultez les sites internet de Proxim et d’Uniprix afin de prendre votre rendez-vous dès aujourd’hui dans la pharmacie la plus près de chez vous. Profitez-en pour recevoir, en même temps et de façon sécuritaire, le vaccin contre la COVID-19.

*Les pharmaciens propriétaires affiliés à Proxim et Uniprix sont les seuls responsables de l’exercice de la pharmacie.

 

À propos de McKesson Canada

McKesson Canada est un chef de file diversifié en matière de services de soins de santé qui se consacre à l’avancement des résultats relatifs à la santé des patients du monde entier. Nos équipes collaborent avec les sociétés biopharmaceutiques, les fournisseurs de soins, les pharmacies, les fabricants, les gouvernements et d’autres intervenants afin de fournir des perspectives, des produits et des services permettant de rendre les soins de qualité plus accessibles et abordables. Apprenez-en davantage sur l’impact de McKesson Canada sur pratiquement tous les aspects des soins de santé sur www.mckesson.ca.

 

Renseignements

Melissa Turgeon

Relations médias pour le Québec

media@mckesson.ca

(514) 601-7280

Publish Date
10/5/22

McKesson Canada's Guardian, I.D.A., Remedy’sRx® and The Medicine Shoppe® Pharmacies Launch Annual Flu Vaccination Campaigns

Mississauga, ON, October 18, 2021 — Today, McKesson Canada’s retail banner group pharmacies, including Guardian®, I.D.A®, Remedy'sRx® and The Medicine Shoppe® launched their annual flu shot campaign.

 

“Our independently owned community pharmacies are at the ready, more than ever following a successful COVID-19 vaccination campaign, to deliver the flu vaccine to Canadians who wish to protect themselves and their loved ones,” said Elyse Desmeules Vice-President of Member and Retail Pharmacy Services, McKesson Canada. “Canadians should feel assured knowing their local pharmacist will be able to provide flu shots with high quality care, knowledge, and a safe environment that prioritizes the health and well-being of patients.”

 

Every year, tens of thousands of Canadians get sick with the flu, putting extra pressure on hospitals and health care systems across the country, which have been strained by the COVID-19 pandemic. While most people will recover after contracting the flu, it can be life-threating for people at high risk such as children, seniors, and those with chronic health conditions.

 

McKesson Canada's banner pharmacies are introducing safety measures to ensure patients feel safe and secure when receiving their flu shot. Depending on participating locations, this may include appointment scheduling, increased sanitation measures and hand sanitizing stations. Local guidelines implemented to protect the public against COVID-19 will also continue to be adhered to, including physical distancing, reduced store capacity and the wearing of face masks or coverings.

 

Protect yourself and your community. Make an appointment today by visiting the websites of Guardian®, I.D.A®, Remedy'sRx® or The Medicine Shoppe® to find the closest pharmacy near you. Availability by province and pharmacy location may vary.

 

– 30 –

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the health care industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other health care institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada.

 

For more information:

Andrew Forgione

Media Relations and Public Affairs Andrew.Forgione@mckesson.ca

905.671.4586

 

Publish Date
10/18/21

McKesson Canada Launches Full-Suite Digital Offering for Patients and Healthcare Professionals

Industry-leading partnership with Auxita simplifies the specialty patient journey

MISSISSAUGA, ON, June 16, 2021 /CNW/ - Today, McKesson Canada is pleased to announce Canada's most robust set of integrated digital solutions intended to enhance specialty physicians' ability to support their patients through their entire healthcare journey. This initiative builds on our ongoing efforts to provide better digital offerings for Canadians.

Canada’s leading end-to-end EMR connected digital network (CNW Group/MCKESSON CANADA)

Canada’s leading end-to-end EMR connected digital network (CNW Group/MCKESSON CANADA)

 

"Managing a patient who requires a specialty medication entails detailed planning and an investment in time and resources to adequately diagnose and provide treatment," said Ramy Ayad, Senior Vice-President, Specialty Health, McKesson Canada. "Our goal with today's announcement is to alleviate the administrative burden on healthcare professionals in areas such as medication access, workflow and communication, so that more time can be spent on what matters most – caring for patients."

 

A strategic partnership delivering market-leading digital capabilities

McKesson Canada, in partnership with leading Canadian technology firm Auxita, is expanding modern digital capabilities to simplify the patient journey. These solutions and capabilities will enable digital connectivity into Patient Support Programs (PSPs), streamlining the clinical workflow and patient experience to navigate complexities related to specialty medications and providing real time data on where the patient is on their treatment journey.

The technology facilitates patient to physician communication and eliminates administrative tasks, creating significant program efficiencies, enhancing the patient experience and shortening the amount of time to receive therapy. The platform will be Electronic Medical Record (EMR) agnostic and will be available for providers who do not have compatible EMRs.

"The Auxita platform is a comprehensive digital health care ecosystem. It delivers actionable insights, evidence-based pathways, simplified enrolment, and seamless communication to improve patient care," said Matt Cahill, CEO at Auxita. "We are looking forward to this partnership positively impacting the lives of Canadians, as we simplify the specialty healthcare experience."

 

A new, simplified specialty patient journey

Unlike existing solutions on the market today, the Auxita platform integrates directly into the existing office workflow. It seamlessly connects with EMRs to provide real time data on where the patient is on their treatment journey.

"As the largest technological initiative in the history of McKesson Canada Specialty Health, the new platform offers intelligent condition-specific alerts and reminders, getting patients started on a treatment plan sooner where a prescription is already available, and creates patient programs that support better treatment outcomes," continued Ayad.

McKesson Canada expects all digital capabilities to be fully operational by December 2021. For more information about this initiative, please contact media@mckesson.ca.

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, our biopharma partners, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

About Auxita

Auxita is a secure digital platform that seamlessly integrates with Electronic Medical Records to link patient data and clinical information across multiple systems. It connects doctors, patients, and patient support programs while eliminating the administrative tasks that can overwhelm today's healthcare providers. Auxita has an established footprint in Canada's healthcare sector and collaborates with strategic partners to ensure a consistent and secure flow of information throughout the patient journey. For more information on Auxita's next-generation medical technology that leads to better care, visit www.auxita.com.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586

Publication Date
21-06-16

McKesson Canada's IDA®, Guardian®, Remedy's Rx® and The Medicine Shoppe® Pharmacies Ready to Protect Canadians Against the Flu

Enhanced health and safety measures implemented to keep patients and employees protected during flu season

 

MISSISSAUGA, ON, Oct. 5, 2020 /CNW/ - Today, McKesson Canada's Retail Banner Group, which includes pharmacies under Guardian®, IDA®, Remedy's Rx® and The Medicine Shoppe® banners, are launching their annual flu shot campaign.

"Community pharmacists play an integral role in our healthcare system, forming a critical part in the fight against the spread of communicable diseases," said George Jeffrey, Senior Vice-President, Retail Banner Group, McKesson Canada.  "This year, McKesson Canada's banner pharmacies are introducing safety measures in addition to COVID-19 health and safety protocols, to ensure patients feel secure when receiving their flu shot."

It is widely anticipated that this year, there will be significant demand for the flu shot, as Canadians actively do their part to protect themselves and their loved ones this flu season. Guardian®, IDA®, Remedy's Rx® and The Medicine Shoppe® are implementing several new tools to help facilitate an easier, more efficient and safe flu shot process this year, including:

  • Appointment scheduling*
  • Flu best practices during the COVID-19 pandemic, such as social distancing, personal protective equipment, capacity limits and disinfection during flu immunization;
  • Enhanced pharmacist education through webinars on best practices;
  • QR code accessible electronic flu consent forms*

*in participating pharmacies only

The flu shot protects individuals against some strains of influenza virus and can be passed on before showing symptoms. This increases the likelihood of patients requiring physician office visits, potential hospital stays or in some cases, death. Getting vaccinated against the flu every year is an important part of keeping Canadians healthy. Contact your local community pharmacist today to schedule your free flu vaccine.

Please visit your local Guardian®, IDA®, Remedy's Rx® or The Medicine Shoppe® website to find the closest pharmacy near you.

 

About McKesson Canada

Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586

Rexall®, IDA®, Guardian®, Remedy's Rx® and The Medicine Shoppe® to Provide Safe and Convenient Access to COVID-19 Testing in Select Locations Across Ontario

McKesson Canada supports Government of Ontario decision to allow COVID-19 testing in pharmacies

 

MISSISSAUGA, ON, Sept. 23, 2020 /CNW Telbec/ - As the fight against COVID-19 continues, select Rexall and McKesson Canada's Retail Banner Group (Guardian®, IDA®, the Medicine Shoppe®, Remedy's Rx®) Ontario pharmacies will begin providing COVID-19 testing for asymptomatic individuals. In order to protect the health and safety of customers, patients and employees, COVID-19 testing within pharmacies must be made through appointment only.

"Pharmacists are increasingly taking on expanded roles in the Canadian healthcare system, while being recognized as essential partners in care delivery," said Rebecca McKillican, CEO, McKesson Canada. "We welcome today's news from the Government of Ontario, instilling confidence in our pharmacists as they continually step up on the frontlines to stop the spread of COVID-19 in our communities."

McKesson Canada is currently supporting COVID-19 testing for asymptomatic patients in Alberta, where IDA®, Guardian®, Remedy's Rx®, the Medicine Shoppe® and Rexall® pharmacies were early adopters as part of the province's original pilot program. McKesson Canada's network of participating pharmacies have conducted thousands of tests to date, and will use the training, tools, and supports developed to ensure best practices are implemented in Ontario.  

"Community pharmacists are proud to be supporting the province's efforts in the fight against COVID-19," continued McKillican. "Increasing the availability of testing is an important step to protect families, loved ones, and the people we encounter on a daily basis."

COVID-19 testing increases Ontario's ability to determine the prevalence of the infection across the province's population and to understand the spread and presence of COVID-19. For more information on which locations offer COVID-19 testing to asymptomatic patients, please visit
https://news.ontario.ca/en/release/58492/ontario-expands-covid-19-testing-to-pharmacies.

 

About McKesson Canada
Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

 

SOURCE MCKESSON CANADA

For further information: Andrew Forgione, Media Relations and Public Affairs, Andrew.Forgione@mckesson.ca, 905.671.4586

White Papers
image
Rare Disease Drugs in Canada: Considerations for Equitable Access

A significant public policy priority for the Government of Canada is ensuring comprehensive, timely, and equitable access to medication for rare diseases; as such, the Government of Canada has allocated $500 million annually to a national strategy for rare disease drugs. McKesson Canada is proud to contribute to this conversation, drawing on experience with patient support programs, pharmaceutical distribution, and specialty pharmacy services. 

image
The $100 Solution: A PostPandemic Path Forward for National Pharmacare in Canada

The Government of Canada would like to develop a solution to ensure universal drug coverage for Canadians. This solution would mean all Canadians would have access to a comprehensive, affordable drug insurance plan regardless of their province of residence or financial situation. Where the coverage comes from is an important consideration, but what ultimately matters is that all Canadians can acquire the medicine they need regardless of their particular financial, geographic or health circumstances. 

image
From Pandemic to Endemic: Lessons from COVID-19 on Improving Vaccination Campaigns in Canada

During the COVID-19 pandemic in Canada, it became clear that any return to 'normal' would only be possible once the majority of Canadians received vaccines. At the time, a COVID-19 vaccine existed only in the designs of biomedical scientists, and most did not anticipate a mass-market vaccine arriving for at least 18 months. In addition to developing the vaccine, the pharmaceutical sector had to conquer the challenge of manufacturing, transporting, storing, and administering billions of doses.